Nicolas Soldermann, based in Mulhouse, Grand Est, FR, is currently a Director and Global Discovery Chemistry Oncology Immunooncology at Novartis Institutes for Biomedical Research (Nibr), bringing experience from previous roles at Novartis Institutes for Biomedical Research (Nibr). Nicolas Soldermann holds a 2002 - 2003 Stanford University. With a robust skill set that includes Drug Discovery, Medicinal Chemistry, Drug Design, Drug Development, Pharmaceutical Industry and more, Nicolas Soldermann contributes valuable insights to the industry. Nicolas Soldermann has 1 email on RocketReach.